Analyse-it
Analyse-it
  • Products
  • Pricing
  • Support
  • About us
Download trial Sign in

19-Nov-2008 Analyse-it speeds Method Validation at National Laboratory

Case studies Method validation Using Analyse-it

Today we’re delighted to publish the second case study into the use of Analyse-it.

The case study features a national clinical laboratory in the USA that offers more than 2,000 tests and combinations to major commercial and government laboratories. They use Analyse-it to determine analytical performance of automated immunoassays for some of the industry’s leading in-vitro diagnostic device makers -- including Abbott Diagnostics, Bayer Diagnostics, Beckman Coulter and Roche Diagnostics.

Unfortunately we cannot name the end-user, or the organisation she works for, in the case study. Although she was delighted to feature in the case study, at final approval her organisation's committee preferred the names be withheld. Thankfully they have allowed us to use the case study, albeit anonymously.

You can read the case study online now or download the Adobe PDF version.

We would love to feature more customer stories in case studies. If you can get approval to participate – which we realise is very difficult in many industries – and have 20 minutes to spare for a telephone interview, please contact us at support@analyse-it.com.

Previous post
Normal quantile & probability plots
Next post
Spot the difference: Numbers stored as text

Comments

Comments are now closed.

Tags
  • All (65)
  • Business (10) 
  • Case studies (2) 
  • Excel (6) 
  • In development (16) 
  • Method validation (19) 
  • Plots (2) 
  • Press releases (1) 
  • Publications (1) 
  • Releases (35) 
  • Statistics (17) 
  • Using Analyse-it (31) 
Latest posts
  • A New Year. A New Edition.
  • Analyse-it v6.10: Survival Analysis and other improvements
  • Analyse-it v5.90: Support for the updated CLSI EP6-Ed2 protocol and inverse predictions
  • Analyse-it 5.50 to 5.65: Recent improvements
  • COVID-19: Calculating the detection limit for a SARS-CoV-2 RT-PCR assay using Analyse-it
  • COVID-19: Calculating PPA/NPA agreement measures using Analyse-it
  • Diagnostic accuracy (sensitivity/specificity) versus agreement (PPA/NPA) statistics
  • COVID-19: Establishing the diagnostic accuracy (sensitivity/specificity) of a test using Analyse-it
  • Why the diagnostic test 'accuracy' statistic is useless
  • Sensitivity/Specificity and The Importance of Predictive Values for a COVID-19 test
Most popular posts
  • Announcing the Analyse-it Quality Control & Improvement Edition
  • Analyse-it 4.0 released: Support for CLSI guidelines, and Measurement Systems Analysis
  • Analyse-it 3.80 released: Principal Component Analysis (PCA)
  • Recent improvements in Analyse-it 3.76 and our first video tutorial!
  • Our software development and validation process
  • The numerical accuracy of Analyse-it against the NIST StRD
  • Quantiles, Percentiles: Why so many ways to calculate them?
  • Handbook of Parametric & Non-parametric Statistical procedures
  • A sombre note: Professor Rick Jones
Products
  • Standard Edition
  • Medical Edition
  • Quality Control & Improvement Edition
  • Method Validation Edition
  • Ultimate Edition
  • Compare Editions
  • Pricing
Support
  • Documentation
  • Tutorials
  • Download latest version
  • Release history
  • Contact support
Company
  • About us
  • Blog
  • Contact us
  • Privacy policy

Get Started

  • Download free trial
  • Sign In

© 2026 Analyse-it® Software, Ltd. All rights reserved.

Statistical analysis and method validation software for Microsoft Excel.

We use essential cookies to run the site, and optional analytics to improve the experience for visitors. For more information see our Privacy policy.